Nextcure announces acceptance of ind application for lncb74

Lncb74 is a b7-h4-targeting antibody-drug conjugate being developed for multiple cancers in partnership with ligachem biosciences lncb74 is a b7-h4-targeting antibody-drug conjugate being developed for multiple cancers in partnership with ligachem biosciences

NXTC Ratings Summary

NXTC Quant Ranking